Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis

Abstract Background Patients with interstitial lung disease (ILD) who show features related to autoimmunity without meeting criteria for a defined connective tissue disease are categorized as interstitial pneumonia with autoimmune features (IPAF). The present study compared clinical characteristics...

Full description

Bibliographic Details
Main Authors: Jeong Uk Lim, Bo Mi Gil, Hye Seon Kang, Jongyeol Oh, Yong Hyun Kim, Soon Seog Kwon
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12890-019-0868-9
_version_ 1819008499850412032
author Jeong Uk Lim
Bo Mi Gil
Hye Seon Kang
Jongyeol Oh
Yong Hyun Kim
Soon Seog Kwon
author_facet Jeong Uk Lim
Bo Mi Gil
Hye Seon Kang
Jongyeol Oh
Yong Hyun Kim
Soon Seog Kwon
author_sort Jeong Uk Lim
collection DOAJ
description Abstract Background Patients with interstitial lung disease (ILD) who show features related to autoimmunity without meeting criteria for a defined connective tissue disease are categorized as interstitial pneumonia with autoimmune features (IPAF). The present study compared clinical characteristics and clinical outcomes of patients with IPAF to patients with connective tissue disease related-interstitial lung disease (CTD-ILD) and patients with idiopathic pulmonary fibrosis (IPF). Methods ILD patients who were consecutively enrolled in a single institution ILD cohort between 2008 and 2015 were evaluated for the study. Clinical data had been prospectively collected, while radiologic imaging and pathologic findings were re-reviewed for the present study. Results Out of 305 patients with ILD, 54 (17.7%) patients met the classification of IPAF, 175 (57.4%) patients had IPF, and 76 (24.9%) patients were diagnosed with CTD-ILD. Compared to IPF, incidences of acute exacerbations in 1,3 and 5 years were significantly less in the IPAF group (p = 0.022, p = 0.026 and p = 0.007, respectively). From multivariate analysis for mortality, age (p = 0.034, HR 1.022, 95% CI: 1.002–1.044), FVC (p < 0.001, HR 0.970, 95% CI: 0.955–0.984), ILD exacerbation (p = 0.001, HR 2.074, 95% CI: 1.366–3.148), and ILD type (p = 0.047, HR 0.436, 95% CI: 0.192–0.984 (IPAF vs IPF), respectively) showed significant association. Conclusions Compared to the other ILD groups, IPAF showed distinct clinical characteristics. The IPAF group showed better survival and less episodes of exacerbation when compared to the IPF group.
first_indexed 2024-12-21T00:41:27Z
format Article
id doaj.art-aa2878105b854e8e82cf99537eff3767
institution Directory Open Access Journal
issn 1471-2466
language English
last_indexed 2024-12-21T00:41:27Z
publishDate 2019-07-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj.art-aa2878105b854e8e82cf99537eff37672022-12-21T19:21:41ZengBMCBMC Pulmonary Medicine1471-24662019-07-0119111010.1186/s12890-019-0868-9Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosisJeong Uk Lim0Bo Mi Gil1Hye Seon Kang2Jongyeol Oh3Yong Hyun Kim4Soon Seog Kwon5Division of Pulmonary and Critical Care Medicine, Department of Medicine, The Armed Forces Capital HospitalDepartment of Radiology, Bucheon St Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of KoreaAbstract Background Patients with interstitial lung disease (ILD) who show features related to autoimmunity without meeting criteria for a defined connective tissue disease are categorized as interstitial pneumonia with autoimmune features (IPAF). The present study compared clinical characteristics and clinical outcomes of patients with IPAF to patients with connective tissue disease related-interstitial lung disease (CTD-ILD) and patients with idiopathic pulmonary fibrosis (IPF). Methods ILD patients who were consecutively enrolled in a single institution ILD cohort between 2008 and 2015 were evaluated for the study. Clinical data had been prospectively collected, while radiologic imaging and pathologic findings were re-reviewed for the present study. Results Out of 305 patients with ILD, 54 (17.7%) patients met the classification of IPAF, 175 (57.4%) patients had IPF, and 76 (24.9%) patients were diagnosed with CTD-ILD. Compared to IPF, incidences of acute exacerbations in 1,3 and 5 years were significantly less in the IPAF group (p = 0.022, p = 0.026 and p = 0.007, respectively). From multivariate analysis for mortality, age (p = 0.034, HR 1.022, 95% CI: 1.002–1.044), FVC (p < 0.001, HR 0.970, 95% CI: 0.955–0.984), ILD exacerbation (p = 0.001, HR 2.074, 95% CI: 1.366–3.148), and ILD type (p = 0.047, HR 0.436, 95% CI: 0.192–0.984 (IPAF vs IPF), respectively) showed significant association. Conclusions Compared to the other ILD groups, IPAF showed distinct clinical characteristics. The IPAF group showed better survival and less episodes of exacerbation when compared to the IPF group.http://link.springer.com/article/10.1186/s12890-019-0868-9Interstitial pneumonia with autoimmune featuresInterstitial lung diseaseConnective tissue diseaseIdiopathic pulmonary fibrosis
spellingShingle Jeong Uk Lim
Bo Mi Gil
Hye Seon Kang
Jongyeol Oh
Yong Hyun Kim
Soon Seog Kwon
Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
BMC Pulmonary Medicine
Interstitial pneumonia with autoimmune features
Interstitial lung disease
Connective tissue disease
Idiopathic pulmonary fibrosis
title Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
title_full Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
title_fullStr Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
title_full_unstemmed Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
title_short Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
title_sort interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
topic Interstitial pneumonia with autoimmune features
Interstitial lung disease
Connective tissue disease
Idiopathic pulmonary fibrosis
url http://link.springer.com/article/10.1186/s12890-019-0868-9
work_keys_str_mv AT jeonguklim interstitialpneumoniawithautoimmunefeaturesshowbettersurvivalandlessexacerbationscomparedtoidiopathicpulmonaryfibrosis
AT bomigil interstitialpneumoniawithautoimmunefeaturesshowbettersurvivalandlessexacerbationscomparedtoidiopathicpulmonaryfibrosis
AT hyeseonkang interstitialpneumoniawithautoimmunefeaturesshowbettersurvivalandlessexacerbationscomparedtoidiopathicpulmonaryfibrosis
AT jongyeoloh interstitialpneumoniawithautoimmunefeaturesshowbettersurvivalandlessexacerbationscomparedtoidiopathicpulmonaryfibrosis
AT yonghyunkim interstitialpneumoniawithautoimmunefeaturesshowbettersurvivalandlessexacerbationscomparedtoidiopathicpulmonaryfibrosis
AT soonseogkwon interstitialpneumoniawithautoimmunefeaturesshowbettersurvivalandlessexacerbationscomparedtoidiopathicpulmonaryfibrosis